Back

Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis

2 September 2024 (08:51 - 09:03)
Organised by: Logo
Congress Presentation Part of: Fine-tuning prognostication after acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Adriana Fonseca Vazao

Leiria Hospital Centre, Leiria (Portugal)

4 More presentations in this session

Presentation thumbnail
Coronary artery plaque characteristics in smokers assessed by intracoronary multi-modality imaging: a NIRS-IVUS guided PROSPECT II substudy
Doctor A. Dahlgren (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Advancing prognostic insights in STEMI patients through microvascular resistance reserve evaluation
Doctor T. Tsai (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Association of PCSK6 rs1531817(C/A) polymorphism with the prognosis and coronary stenosis in premature myocardial infarction patients: a prospective cohort study
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Minimal coronary microvascular resistance: agreement between continuous and bolus thermodilution
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Fine-tuning prognostication after acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Impact of antiplatelet pretreatment on stent thrombosis in patients undergoing PCI in real world practice: insight France PCI registry
thumbnail
Congress Presentation
Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study
thumbnail
Congress Session
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources